nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—Abnormal pigmentation—Temozolomide—malignant glioma	0.0222	0.0637	CcSEcCtD
Cyclosporine—Lung fibrosis interstitial—Carmustine—malignant glioma	0.0188	0.0539	CcSEcCtD
Cyclosporine—PPP3CA—pons—malignant glioma	0.0162	0.0663	CbGeAlD
Cyclosporine—Wound—Carmustine—malignant glioma	0.0149	0.0428	CcSEcCtD
Cyclosporine—PPP3CA—telencephalic ventricle—malignant glioma	0.0134	0.0546	CbGeAlD
Cyclosporine—Nephrotoxicity—Carmustine—malignant glioma	0.0068	0.0196	CcSEcCtD
Cyclosporine—Pigmentation disorder—Temozolomide—malignant glioma	0.00626	0.018	CcSEcCtD
Cyclosporine—FKBP4—embryo—malignant glioma	0.00614	0.0251	CbGeAlD
Cyclosporine—Paresis—Temozolomide—malignant glioma	0.00573	0.0165	CcSEcCtD
Cyclosporine—Traumatic liver injury—Temozolomide—malignant glioma	0.00561	0.0161	CcSEcCtD
Cyclosporine—CAMLG—brainstem—malignant glioma	0.00512	0.0209	CbGeAlD
Cyclosporine—PPID—retina—malignant glioma	0.00501	0.0205	CbGeAlD
Cyclosporine—FKBP4—telencephalon—malignant glioma	0.005	0.0204	CbGeAlD
Cyclosporine—CAMLG—retina—malignant glioma	0.00494	0.0202	CbGeAlD
Cyclosporine—PPID—telencephalon—malignant glioma	0.00461	0.0188	CbGeAlD
Cyclosporine—CAMLG—telencephalon—malignant glioma	0.00454	0.0186	CbGeAlD
Cyclosporine—Altered state of consciousness—Temozolomide—malignant glioma	0.00453	0.013	CcSEcCtD
Cyclosporine—PPIA—retina—malignant glioma	0.0045	0.0184	CbGeAlD
Cyclosporine—FKBP1B—central nervous system—malignant glioma	0.00429	0.0175	CbGeAlD
Cyclosporine—FKBP1B—cerebellum—malignant glioma	0.0042	0.0171	CbGeAlD
Cyclosporine—Azotaemia—Carmustine—malignant glioma	0.00406	0.0117	CcSEcCtD
Cyclosporine—Nephropathy toxic—Carmustine—malignant glioma	0.00376	0.0108	CcSEcCtD
Cyclosporine—PPIF—retina—malignant glioma	0.00364	0.0149	CbGeAlD
Cyclosporine—PPID—medulla oblongata—malignant glioma	0.00362	0.0148	CbGeAlD
Cyclosporine—PPP3CA—brainstem—malignant glioma	0.00362	0.0148	CbGeAlD
Cyclosporine—CAMLG—medulla oblongata—malignant glioma	0.00357	0.0146	CbGeAlD
Cyclosporine—Cerebration impaired—Temozolomide—malignant glioma	0.00355	0.0102	CcSEcCtD
Cyclosporine—FKBP4—spinal cord—malignant glioma	0.0035	0.0143	CbGeAlD
Cyclosporine—PPP3CA—retina—malignant glioma	0.00349	0.0142	CbGeAlD
Cyclosporine—FKBP1B—brain—malignant glioma	0.00341	0.0139	CbGeAlD
Cyclosporine—Encephalopathy—Carmustine—malignant glioma	0.00337	0.00969	CcSEcCtD
Cyclosporine—PPIF—telencephalon—malignant glioma	0.00335	0.0137	CbGeAlD
Cyclosporine—PPID—midbrain—malignant glioma	0.00331	0.0135	CbGeAlD
Cyclosporine—CAMLG—midbrain—malignant glioma	0.00326	0.0133	CbGeAlD
Cyclosporine—PPIA—medulla oblongata—malignant glioma	0.00325	0.0133	CbGeAlD
Cyclosporine—Cyst—Carmustine—malignant glioma	0.00323	0.0093	CcSEcCtD
Cyclosporine—PPID—spinal cord—malignant glioma	0.00323	0.0132	CbGeAlD
Cyclosporine—Tooth disorder—Temozolomide—malignant glioma	0.00322	0.00926	CcSEcCtD
Cyclosporine—PPP3CA—telencephalon—malignant glioma	0.00321	0.0131	CbGeAlD
Cyclosporine—PPIB—telencephalon—malignant glioma	0.00319	0.013	CbGeAlD
Cyclosporine—CAMLG—spinal cord—malignant glioma	0.00318	0.013	CbGeAlD
Cyclosporine—Digestion impaired—Temozolomide—malignant glioma	0.00313	0.00899	CcSEcCtD
Cyclosporine—Burning sensation—Carmustine—malignant glioma	0.00311	0.00895	CcSEcCtD
Cyclosporine—Thrombosis—Carmustine—malignant glioma	0.00305	0.00878	CcSEcCtD
Cyclosporine—Interstitial lung disease—Carmustine—malignant glioma	0.00305	0.00878	CcSEcCtD
Cyclosporine—Myopathy—Temozolomide—malignant glioma	0.00298	0.00857	CcSEcCtD
Cyclosporine—PPIA—midbrain—malignant glioma	0.00297	0.0121	CbGeAlD
Cyclosporine—Interstitial lung disease—Temozolomide—malignant glioma	0.00295	0.00849	CcSEcCtD
Cyclosporine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00293	0.00841	CcSEcCtD
Cyclosporine—PPIA—spinal cord—malignant glioma	0.0029	0.0118	CbGeAlD
Cyclosporine—FKBP4—central nervous system—malignant glioma	0.00284	0.0116	CbGeAlD
Cyclosporine—Hepatotoxicity—Carmustine—malignant glioma	0.0028	0.00805	CcSEcCtD
Cyclosporine—FKBP4—cerebellum—malignant glioma	0.00278	0.0113	CbGeAlD
Cyclosporine—Herpes zoster—Temozolomide—malignant glioma	0.00277	0.00798	CcSEcCtD
Cyclosporine—Cholestasis—Temozolomide—malignant glioma	0.00275	0.00791	CcSEcCtD
Cyclosporine—Abscess—Carmustine—malignant glioma	0.00273	0.00786	CcSEcCtD
Cyclosporine—Hepatotoxicity—Temozolomide—malignant glioma	0.00271	0.00778	CcSEcCtD
Cyclosporine—Coagulopathy—Temozolomide—malignant glioma	0.00268	0.00772	CcSEcCtD
Cyclosporine—Hyperaesthesia—Temozolomide—malignant glioma	0.00266	0.00765	CcSEcCtD
Cyclosporine—PPIF—medulla oblongata—malignant glioma	0.00263	0.0108	CbGeAlD
Cyclosporine—PPID—central nervous system—malignant glioma	0.00262	0.0107	CbGeAlD
Cyclosporine—CAMLG—central nervous system—malignant glioma	0.00258	0.0105	CbGeAlD
Cyclosporine—PPID—cerebellum—malignant glioma	0.00256	0.0105	CbGeAlD
Cyclosporine—Rigors—Temozolomide—malignant glioma	0.00256	0.00736	CcSEcCtD
Cyclosporine—CAMLG—cerebellum—malignant glioma	0.00252	0.0103	CbGeAlD
Cyclosporine—PPP3CA—medulla oblongata—malignant glioma	0.00252	0.0103	CbGeAlD
Cyclosporine—PPIB—medulla oblongata—malignant glioma	0.00251	0.0102	CbGeAlD
Cyclosporine—Liver injury—Temozolomide—malignant glioma	0.00248	0.00714	CcSEcCtD
Cyclosporine—Disturbance in attention—Temozolomide—malignant glioma	0.00241	0.00694	CcSEcCtD
Cyclosporine—PPIF—midbrain—malignant glioma	0.00241	0.00983	CbGeAlD
Cyclosporine—Breast pain—Temozolomide—malignant glioma	0.00239	0.00689	CcSEcCtD
Cyclosporine—Amenorrhoea—Temozolomide—malignant glioma	0.00238	0.00684	CcSEcCtD
Cyclosporine—PPIF—spinal cord—malignant glioma	0.00235	0.00959	CbGeAlD
Cyclosporine—FKBP1A—retina—malignant glioma	0.00232	0.00947	CbGeAlD
Cyclosporine—Viral infection—Temozolomide—malignant glioma	0.00231	0.00665	CcSEcCtD
Cyclosporine—PPP3CA—midbrain—malignant glioma	0.0023	0.00941	CbGeAlD
Cyclosporine—PPIA—cerebellum—malignant glioma	0.0023	0.00939	CbGeAlD
Cyclosporine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0023	0.00661	CcSEcCtD
Cyclosporine—PPIB—midbrain—malignant glioma	0.00229	0.00936	CbGeAlD
Cyclosporine—Herpes simplex—Temozolomide—malignant glioma	0.00227	0.00652	CcSEcCtD
Cyclosporine—FKBP4—brain—malignant glioma	0.00225	0.0092	CbGeAlD
Cyclosporine—PPP3CA—spinal cord—malignant glioma	0.00225	0.00918	CbGeAlD
Cyclosporine—PPIB—spinal cord—malignant glioma	0.00224	0.00913	CbGeAlD
Cyclosporine—Hearing impaired—Temozolomide—malignant glioma	0.00219	0.00631	CcSEcCtD
Cyclosporine—FKBP1A—telencephalon—malignant glioma	0.00213	0.00871	CbGeAlD
Cyclosporine—Urinary incontinence—Carmustine—malignant glioma	0.00209	0.006	CcSEcCtD
Cyclosporine—PPID—brain—malignant glioma	0.00208	0.00849	CbGeAlD
Cyclosporine—Candida infection—Carmustine—malignant glioma	0.00206	0.00594	CcSEcCtD
Cyclosporine—CAMLG—brain—malignant glioma	0.00205	0.00837	CbGeAlD
Cyclosporine—Neuropathy—Carmustine—malignant glioma	0.00203	0.00584	CcSEcCtD
Cyclosporine—Influenza like illness—Temozolomide—malignant glioma	0.00203	0.00583	CcSEcCtD
Cyclosporine—Urinary incontinence—Temozolomide—malignant glioma	0.00202	0.0058	CcSEcCtD
Cyclosporine—Candida infection—Temozolomide—malignant glioma	0.00199	0.00574	CcSEcCtD
Cyclosporine—Coma—Carmustine—malignant glioma	0.00198	0.00568	CcSEcCtD
Cyclosporine—Neuropathy—Temozolomide—malignant glioma	0.00196	0.00564	CcSEcCtD
Cyclosporine—Neoplasm—Carmustine—malignant glioma	0.00195	0.00562	CcSEcCtD
Cyclosporine—Gynaecomastia—Carmustine—malignant glioma	0.00193	0.00556	CcSEcCtD
Cyclosporine—PPIF—central nervous system—malignant glioma	0.00191	0.00778	CbGeAlD
Cyclosporine—Neoplasm—Temozolomide—malignant glioma	0.00189	0.00543	CcSEcCtD
Cyclosporine—Abnormal vision—Carmustine—malignant glioma	0.00189	0.00542	CcSEcCtD
Cyclosporine—Sepsis—Carmustine—malignant glioma	0.00188	0.0054	CcSEcCtD
Cyclosporine—Mental disability—Carmustine—malignant glioma	0.00188	0.0054	CcSEcCtD
Cyclosporine—PPIA—brain—malignant glioma	0.00187	0.00763	CbGeAlD
Cyclosporine—PPIF—cerebellum—malignant glioma	0.00186	0.0076	CbGeAlD
Cyclosporine—PPP3CA—central nervous system—malignant glioma	0.00182	0.00745	CbGeAlD
Cyclosporine—Abnormal vision—Temozolomide—malignant glioma	0.00182	0.00524	CcSEcCtD
Cyclosporine—PPIB—central nervous system—malignant glioma	0.00181	0.00741	CbGeAlD
Cyclosporine—Mental disability—Temozolomide—malignant glioma	0.00181	0.00521	CcSEcCtD
Cyclosporine—Diabetes mellitus—Carmustine—malignant glioma	0.0018	0.00519	CcSEcCtD
Cyclosporine—PPP3CA—cerebellum—malignant glioma	0.00178	0.00728	CbGeAlD
Cyclosporine—PPIB—cerebellum—malignant glioma	0.00177	0.00724	CbGeAlD
Cyclosporine—Eye pain—Carmustine—malignant glioma	0.00174	0.005	CcSEcCtD
Cyclosporine—Gastroenteritis—Temozolomide—malignant glioma	0.00171	0.00492	CcSEcCtD
Cyclosporine—ABCC10—telencephalon—malignant glioma	0.00171	0.00698	CbGeAlD
Cyclosporine—Injury—Carmustine—malignant glioma	0.00171	0.00491	CcSEcCtD
Cyclosporine—Vascular purpura—Temozolomide—malignant glioma	0.0017	0.00488	CcSEcCtD
Cyclosporine—Deafness—Temozolomide—malignant glioma	0.0017	0.00488	CcSEcCtD
Cyclosporine—Hepatic failure—Temozolomide—malignant glioma	0.00169	0.00485	CcSEcCtD
Cyclosporine—Eye pain—Temozolomide—malignant glioma	0.00168	0.00483	CcSEcCtD
Cyclosporine—FKBP1A—medulla oblongata—malignant glioma	0.00168	0.00684	CbGeAlD
Cyclosporine—Hot flush—Temozolomide—malignant glioma	0.00162	0.00466	CcSEcCtD
Cyclosporine—Menopausal symptoms—Temozolomide—malignant glioma	0.00161	0.00462	CcSEcCtD
Cyclosporine—Purpura—Temozolomide—malignant glioma	0.00157	0.00452	CcSEcCtD
Cyclosporine—SLC10A1—central nervous system—malignant glioma	0.00155	0.00633	CbGeAlD
Cyclosporine—FKBP1A—midbrain—malignant glioma	0.00153	0.00625	CbGeAlD
Cyclosporine—PPIF—brain—malignant glioma	0.00151	0.00618	CbGeAlD
Cyclosporine—FKBP1A—spinal cord—malignant glioma	0.00149	0.0061	CbGeAlD
Cyclosporine—Affect lability—Temozolomide—malignant glioma	0.00149	0.00429	CcSEcCtD
Cyclosporine—SLCO1A2—telencephalon—malignant glioma	0.00147	0.00601	CbGeAlD
Cyclosporine—PPP3CA—brain—malignant glioma	0.00145	0.00591	CbGeAlD
Cyclosporine—PPIB—brain—malignant glioma	0.00144	0.00588	CbGeAlD
Cyclosporine—Mood swings—Temozolomide—malignant glioma	0.00144	0.00413	CcSEcCtD
Cyclosporine—Dry skin—Temozolomide—malignant glioma	0.00139	0.004	CcSEcCtD
Cyclosporine—Muscular weakness—Carmustine—malignant glioma	0.00138	0.00398	CcSEcCtD
Cyclosporine—Breast disorder—Temozolomide—malignant glioma	0.00137	0.00394	CcSEcCtD
Cyclosporine—Dysphagia—Carmustine—malignant glioma	0.00136	0.0039	CcSEcCtD
Cyclosporine—ABCC10—medulla oblongata—malignant glioma	0.00134	0.00548	CbGeAlD
Cyclosporine—Muscular weakness—Temozolomide—malignant glioma	0.00134	0.00385	CcSEcCtD
Cyclosporine—Abdominal distension—Temozolomide—malignant glioma	0.00132	0.00379	CcSEcCtD
Cyclosporine—Dysphagia—Temozolomide—malignant glioma	0.00131	0.00377	CcSEcCtD
Cyclosporine—Sweating increased—Temozolomide—malignant glioma	0.00128	0.00367	CcSEcCtD
Cyclosporine—Bronchitis—Temozolomide—malignant glioma	0.00126	0.00363	CcSEcCtD
Cyclosporine—SLC10A1—brain—malignant glioma	0.00123	0.00503	CbGeAlD
Cyclosporine—ABCC10—midbrain—malignant glioma	0.00123	0.00501	CbGeAlD
Cyclosporine—Dysuria—Temozolomide—malignant glioma	0.00123	0.00352	CcSEcCtD
Cyclosporine—Hyperglycaemia—Carmustine—malignant glioma	0.00122	0.00352	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00122	0.0035	CcSEcCtD
Cyclosporine—Pneumonia—Carmustine—malignant glioma	0.00122	0.0035	CcSEcCtD
Cyclosporine—FKBP1A—central nervous system—malignant glioma	0.00121	0.00495	CbGeAlD
Cyclosporine—Pollakiuria—Temozolomide—malignant glioma	0.00121	0.00348	CcSEcCtD
Cyclosporine—ABCC1—telencephalon—malignant glioma	0.00121	0.00493	CbGeAlD
Cyclosporine—Depression—Carmustine—malignant glioma	0.00121	0.00347	CcSEcCtD
Cyclosporine—ABCC10—spinal cord—malignant glioma	0.0012	0.00489	CbGeAlD
Cyclosporine—Weight increased—Temozolomide—malignant glioma	0.00119	0.00343	CcSEcCtD
Cyclosporine—Renal failure—Carmustine—malignant glioma	0.00119	0.00342	CcSEcCtD
Cyclosporine—Weight decreased—Temozolomide—malignant glioma	0.00119	0.00341	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Carmustine—malignant glioma	0.00119	0.00341	CcSEcCtD
Cyclosporine—FKBP1A—cerebellum—malignant glioma	0.00118	0.00484	CbGeAlD
Cyclosporine—Hyperglycaemia—Temozolomide—malignant glioma	0.00118	0.0034	CcSEcCtD
Cyclosporine—Stomatitis—Carmustine—malignant glioma	0.00118	0.00339	CcSEcCtD
Cyclosporine—Urinary tract infection—Carmustine—malignant glioma	0.00118	0.00338	CcSEcCtD
Cyclosporine—Pneumonia—Temozolomide—malignant glioma	0.00118	0.00338	CcSEcCtD
Cyclosporine—Infestation NOS—Temozolomide—malignant glioma	0.00117	0.00336	CcSEcCtD
Cyclosporine—Infestation—Temozolomide—malignant glioma	0.00117	0.00336	CcSEcCtD
Cyclosporine—Depression—Temozolomide—malignant glioma	0.00117	0.00335	CcSEcCtD
Cyclosporine—SLCO1A2—medulla oblongata—malignant glioma	0.00116	0.00472	CbGeAlD
Cyclosporine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00115	0.00329	CcSEcCtD
Cyclosporine—Stomatitis—Temozolomide—malignant glioma	0.00114	0.00328	CcSEcCtD
Cyclosporine—Urinary tract infection—Temozolomide—malignant glioma	0.00114	0.00327	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00111	0.00318	CcSEcCtD
Cyclosporine—Sinusitis—Temozolomide—malignant glioma	0.0011	0.00315	CcSEcCtD
Cyclosporine—Haemoglobin—Carmustine—malignant glioma	0.00109	0.00314	CcSEcCtD
Cyclosporine—Haemorrhage—Carmustine—malignant glioma	0.00109	0.00312	CcSEcCtD
Cyclosporine—Hypoaesthesia—Carmustine—malignant glioma	0.00108	0.00311	CcSEcCtD
Cyclosporine—Connective tissue disorder—Carmustine—malignant glioma	0.00107	0.00307	CcSEcCtD
Cyclosporine—SLC22A6—brain—malignant glioma	0.00106	0.00433	CbGeAlD
Cyclosporine—SLCO1A2—midbrain—malignant glioma	0.00106	0.00432	CbGeAlD
Cyclosporine—Haemoglobin—Temozolomide—malignant glioma	0.00105	0.00303	CcSEcCtD
Cyclosporine—Hepatitis—Temozolomide—malignant glioma	0.00105	0.00302	CcSEcCtD
Cyclosporine—Haemorrhage—Temozolomide—malignant glioma	0.00105	0.00302	CcSEcCtD
Cyclosporine—Visual impairment—Carmustine—malignant glioma	0.00105	0.00301	CcSEcCtD
Cyclosporine—Hypoaesthesia—Temozolomide—malignant glioma	0.00104	0.003	CcSEcCtD
Cyclosporine—Pharyngitis—Temozolomide—malignant glioma	0.00104	0.00299	CcSEcCtD
Cyclosporine—Urinary tract disorder—Temozolomide—malignant glioma	0.00104	0.00298	CcSEcCtD
Cyclosporine—SLCO1A2—spinal cord—malignant glioma	0.00103	0.00421	CbGeAlD
Cyclosporine—Connective tissue disorder—Temozolomide—malignant glioma	0.00103	0.00296	CcSEcCtD
Cyclosporine—Urethral disorder—Temozolomide—malignant glioma	0.00103	0.00296	CcSEcCtD
Cyclosporine—ABCB1—blood vessel—malignant glioma	0.00102	0.00415	CbGeAlD
Cyclosporine—Visual impairment—Temozolomide—malignant glioma	0.00101	0.00291	CcSEcCtD
Cyclosporine—Flushing—Carmustine—malignant glioma	0.00101	0.0029	CcSEcCtD
Cyclosporine—ABCG2—telencephalon—malignant glioma	0.001	0.00408	CbGeAlD
Cyclosporine—Tinnitus—Temozolomide—malignant glioma	0.000978	0.00281	CcSEcCtD
Cyclosporine—ABCC3—central nervous system—malignant glioma	0.000976	0.00398	CbGeAlD
Cyclosporine—Flushing—Temozolomide—malignant glioma	0.000974	0.0028	CcSEcCtD
Cyclosporine—Arrhythmia—Carmustine—malignant glioma	0.00097	0.00279	CcSEcCtD
Cyclosporine—FKBP1A—brain—malignant glioma	0.000962	0.00393	CbGeAlD
Cyclosporine—Alopecia—Carmustine—malignant glioma	0.000959	0.00276	CcSEcCtD
Cyclosporine—Angiopathy—Temozolomide—malignant glioma	0.000952	0.00274	CcSEcCtD
Cyclosporine—Mental disorder—Carmustine—malignant glioma	0.000951	0.00274	CcSEcCtD
Cyclosporine—ABCC10—cerebellum—malignant glioma	0.000949	0.00388	CbGeAlD
Cyclosporine—Mediastinal disorder—Temozolomide—malignant glioma	0.000946	0.00272	CcSEcCtD
Cyclosporine—Malnutrition—Carmustine—malignant glioma	0.000945	0.00272	CcSEcCtD
Cyclosporine—Chills—Temozolomide—malignant glioma	0.000941	0.00271	CcSEcCtD
Cyclosporine—Alopecia—Temozolomide—malignant glioma	0.000927	0.00267	CcSEcCtD
Cyclosporine—Mental disorder—Temozolomide—malignant glioma	0.000919	0.00264	CcSEcCtD
Cyclosporine—Malnutrition—Temozolomide—malignant glioma	0.000913	0.00263	CcSEcCtD
Cyclosporine—Dysgeusia—Temozolomide—malignant glioma	0.000894	0.00257	CcSEcCtD
Cyclosporine—Vision blurred—Carmustine—malignant glioma	0.000891	0.00256	CcSEcCtD
Cyclosporine—Tremor—Carmustine—malignant glioma	0.000886	0.00255	CcSEcCtD
Cyclosporine—Anaemia—Carmustine—malignant glioma	0.000874	0.00251	CcSEcCtD
Cyclosporine—Agitation—Carmustine—malignant glioma	0.000869	0.0025	CcSEcCtD
Cyclosporine—Vision blurred—Temozolomide—malignant glioma	0.000861	0.00248	CcSEcCtD
Cyclosporine—Tremor—Temozolomide—malignant glioma	0.000856	0.00246	CcSEcCtD
Cyclosporine—Ill-defined disorder—Temozolomide—malignant glioma	0.000847	0.00244	CcSEcCtD
Cyclosporine—Leukopenia—Carmustine—malignant glioma	0.000846	0.00243	CcSEcCtD
Cyclosporine—Anaemia—Temozolomide—malignant glioma	0.000844	0.00243	CcSEcCtD
Cyclosporine—Agitation—Temozolomide—malignant glioma	0.000839	0.00241	CcSEcCtD
Cyclosporine—SLCO1A2—central nervous system—malignant glioma	0.000837	0.00342	CbGeAlD
Cyclosporine—Angioedema—Temozolomide—malignant glioma	0.000835	0.0024	CcSEcCtD
Cyclosporine—Malaise—Temozolomide—malignant glioma	0.000824	0.00237	CcSEcCtD
Cyclosporine—Vertigo—Temozolomide—malignant glioma	0.000821	0.00236	CcSEcCtD
Cyclosporine—Convulsion—Carmustine—malignant glioma	0.000819	0.00235	CcSEcCtD
Cyclosporine—SLCO1A2—cerebellum—malignant glioma	0.000818	0.00334	CbGeAlD
Cyclosporine—Leukopenia—Temozolomide—malignant glioma	0.000818	0.00235	CcSEcCtD
Cyclosporine—Hypertension—Carmustine—malignant glioma	0.000816	0.00235	CcSEcCtD
Cyclosporine—Chest pain—Carmustine—malignant glioma	0.000805	0.00231	CcSEcCtD
Cyclosporine—Myalgia—Carmustine—malignant glioma	0.000805	0.00231	CcSEcCtD
Cyclosporine—Anxiety—Carmustine—malignant glioma	0.000802	0.00231	CcSEcCtD
Cyclosporine—Cough—Temozolomide—malignant glioma	0.000797	0.00229	CcSEcCtD
Cyclosporine—Convulsion—Temozolomide—malignant glioma	0.000791	0.00228	CcSEcCtD
Cyclosporine—Hypertension—Temozolomide—malignant glioma	0.000789	0.00227	CcSEcCtD
Cyclosporine—ABCG2—medulla oblongata—malignant glioma	0.000786	0.00321	CbGeAlD
Cyclosporine—Confusional state—Carmustine—malignant glioma	0.000778	0.00224	CcSEcCtD
Cyclosporine—Myalgia—Temozolomide—malignant glioma	0.000778	0.00224	CcSEcCtD
Cyclosporine—Arthralgia—Temozolomide—malignant glioma	0.000778	0.00224	CcSEcCtD
Cyclosporine—Anxiety—Temozolomide—malignant glioma	0.000775	0.00223	CcSEcCtD
Cyclosporine—ABCC3—brain—malignant glioma	0.000775	0.00316	CbGeAlD
Cyclosporine—CYP2D6—brainstem—malignant glioma	0.000773	0.00316	CbGeAlD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000772	0.00222	CcSEcCtD
Cyclosporine—Oedema—Carmustine—malignant glioma	0.000771	0.00222	CcSEcCtD
Cyclosporine—ABCC10—brain—malignant glioma	0.000771	0.00315	CbGeAlD
Cyclosporine—Discomfort—Temozolomide—malignant glioma	0.000768	0.00221	CcSEcCtD
Cyclosporine—Infection—Carmustine—malignant glioma	0.000766	0.0022	CcSEcCtD
Cyclosporine—Dry mouth—Temozolomide—malignant glioma	0.000761	0.00219	CcSEcCtD
Cyclosporine—Thrombocytopenia—Carmustine—malignant glioma	0.000755	0.00217	CcSEcCtD
Cyclosporine—Confusional state—Temozolomide—malignant glioma	0.000752	0.00216	CcSEcCtD
Cyclosporine—Anaphylactic shock—Temozolomide—malignant glioma	0.000745	0.00214	CcSEcCtD
Cyclosporine—Oedema—Temozolomide—malignant glioma	0.000745	0.00214	CcSEcCtD
Cyclosporine—Infection—Temozolomide—malignant glioma	0.000741	0.00213	CcSEcCtD
Cyclosporine—Anorexia—Carmustine—malignant glioma	0.000735	0.00211	CcSEcCtD
Cyclosporine—Nervous system disorder—Temozolomide—malignant glioma	0.000731	0.0021	CcSEcCtD
Cyclosporine—Thrombocytopenia—Temozolomide—malignant glioma	0.00073	0.0021	CcSEcCtD
Cyclosporine—Skin disorder—Temozolomide—malignant glioma	0.000724	0.00208	CcSEcCtD
Cyclosporine—Hyperhidrosis—Temozolomide—malignant glioma	0.000721	0.00207	CcSEcCtD
Cyclosporine—ABCG2—midbrain—malignant glioma	0.000718	0.00293	CbGeAlD
Cyclosporine—Anorexia—Temozolomide—malignant glioma	0.000711	0.00204	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000703	0.00202	CcSEcCtD
Cyclosporine—ABCG2—spinal cord—malignant glioma	0.000701	0.00286	CbGeAlD
Cyclosporine—Insomnia—Carmustine—malignant glioma	0.000698	0.00201	CcSEcCtD
Cyclosporine—Paraesthesia—Carmustine—malignant glioma	0.000693	0.00199	CcSEcCtD
Cyclosporine—Dyspnoea—Carmustine—malignant glioma	0.000688	0.00198	CcSEcCtD
Cyclosporine—Somnolence—Carmustine—malignant glioma	0.000686	0.00197	CcSEcCtD
Cyclosporine—CYP2D6—telencephalon—malignant glioma	0.000686	0.0028	CbGeAlD
Cyclosporine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000679	0.00195	CcSEcCtD
Cyclosporine—Insomnia—Temozolomide—malignant glioma	0.000674	0.00194	CcSEcCtD
Cyclosporine—ABCC1—cerebellum—malignant glioma	0.000671	0.00274	CbGeAlD
Cyclosporine—Decreased appetite—Carmustine—malignant glioma	0.000671	0.00193	CcSEcCtD
Cyclosporine—Paraesthesia—Temozolomide—malignant glioma	0.000669	0.00192	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000666	0.00191	CcSEcCtD
Cyclosporine—Dyspnoea—Temozolomide—malignant glioma	0.000665	0.00191	CcSEcCtD
Cyclosporine—SLCO1A2—brain—malignant glioma	0.000664	0.00271	CbGeAlD
Cyclosporine—Somnolence—Temozolomide—malignant glioma	0.000663	0.00191	CcSEcCtD
Cyclosporine—Pain—Carmustine—malignant glioma	0.00066	0.0019	CcSEcCtD
Cyclosporine—Constipation—Carmustine—malignant glioma	0.00066	0.0019	CcSEcCtD
Cyclosporine—Dyspepsia—Temozolomide—malignant glioma	0.000656	0.00189	CcSEcCtD
Cyclosporine—Decreased appetite—Temozolomide—malignant glioma	0.000648	0.00186	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000644	0.00185	CcSEcCtD
Cyclosporine—Fatigue—Temozolomide—malignant glioma	0.000643	0.00185	CcSEcCtD
Cyclosporine—Pain—Temozolomide—malignant glioma	0.000637	0.00183	CcSEcCtD
Cyclosporine—Constipation—Temozolomide—malignant glioma	0.000637	0.00183	CcSEcCtD
Cyclosporine—Feeling abnormal—Carmustine—malignant glioma	0.000636	0.00183	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Carmustine—malignant glioma	0.000631	0.00181	CcSEcCtD
Cyclosporine—Feeling abnormal—Temozolomide—malignant glioma	0.000614	0.00177	CcSEcCtD
Cyclosporine—Abdominal pain—Carmustine—malignant glioma	0.00061	0.00175	CcSEcCtD
Cyclosporine—Body temperature increased—Carmustine—malignant glioma	0.00061	0.00175	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00061	0.00175	CcSEcCtD
Cyclosporine—ABCB1—embryo—malignant glioma	0.000607	0.00248	CbGeAlD
Cyclosporine—Urticaria—Temozolomide—malignant glioma	0.000592	0.0017	CcSEcCtD
Cyclosporine—Body temperature increased—Temozolomide—malignant glioma	0.000589	0.00169	CcSEcCtD
Cyclosporine—Abdominal pain—Temozolomide—malignant glioma	0.000589	0.00169	CcSEcCtD
Cyclosporine—Hypersensitivity—Carmustine—malignant glioma	0.000568	0.00163	CcSEcCtD
Cyclosporine—ABCG2—cerebellum—malignant glioma	0.000556	0.00227	CbGeAlD
Cyclosporine—Asthenia—Carmustine—malignant glioma	0.000553	0.00159	CcSEcCtD
Cyclosporine—Hypersensitivity—Temozolomide—malignant glioma	0.000549	0.00158	CcSEcCtD
Cyclosporine—ABCC1—brain—malignant glioma	0.000545	0.00223	CbGeAlD
Cyclosporine—ABCB1—retina—malignant glioma	0.000536	0.00219	CbGeAlD
Cyclosporine—Asthenia—Temozolomide—malignant glioma	0.000535	0.00154	CcSEcCtD
Cyclosporine—Diarrhoea—Carmustine—malignant glioma	0.000528	0.00152	CcSEcCtD
Cyclosporine—Pruritus—Temozolomide—malignant glioma	0.000527	0.00152	CcSEcCtD
Cyclosporine—Dizziness—Carmustine—malignant glioma	0.00051	0.00147	CcSEcCtD
Cyclosporine—Diarrhoea—Temozolomide—malignant glioma	0.00051	0.00147	CcSEcCtD
Cyclosporine—ABCB1—telencephalon—malignant glioma	0.000493	0.00201	CbGeAlD
Cyclosporine—Dizziness—Temozolomide—malignant glioma	0.000493	0.00142	CcSEcCtD
Cyclosporine—Vomiting—Carmustine—malignant glioma	0.00049	0.00141	CcSEcCtD
Cyclosporine—Rash—Carmustine—malignant glioma	0.000486	0.0014	CcSEcCtD
Cyclosporine—Dermatitis—Carmustine—malignant glioma	0.000486	0.0014	CcSEcCtD
Cyclosporine—Headache—Carmustine—malignant glioma	0.000483	0.00139	CcSEcCtD
Cyclosporine—Vomiting—Temozolomide—malignant glioma	0.000474	0.00136	CcSEcCtD
Cyclosporine—Rash—Temozolomide—malignant glioma	0.00047	0.00135	CcSEcCtD
Cyclosporine—Dermatitis—Temozolomide—malignant glioma	0.00047	0.00135	CcSEcCtD
Cyclosporine—Headache—Temozolomide—malignant glioma	0.000467	0.00134	CcSEcCtD
Cyclosporine—CYP2C8—brain—malignant glioma	0.000464	0.0019	CbGeAlD
Cyclosporine—Nausea—Carmustine—malignant glioma	0.000458	0.00132	CcSEcCtD
Cyclosporine—ABCG2—brain—malignant glioma	0.000451	0.00184	CbGeAlD
Cyclosporine—Nausea—Temozolomide—malignant glioma	0.000443	0.00127	CcSEcCtD
Cyclosporine—CYP3A4—central nervous system—malignant glioma	0.000396	0.00162	CbGeAlD
Cyclosporine—CYP2D6—central nervous system—malignant glioma	0.00039	0.00159	CbGeAlD
Cyclosporine—ABCB1—medulla oblongata—malignant glioma	0.000388	0.00158	CbGeAlD
Cyclosporine—CYP2D6—cerebellum—malignant glioma	0.000381	0.00156	CbGeAlD
Cyclosporine—ABCB1—midbrain—malignant glioma	0.000354	0.00145	CbGeAlD
Cyclosporine—ABCB1—spinal cord—malignant glioma	0.000346	0.00141	CbGeAlD
Cyclosporine—CYP2D6—brain—malignant glioma	0.000309	0.00126	CbGeAlD
Cyclosporine—ABCB1—central nervous system—malignant glioma	0.00028	0.00114	CbGeAlD
Cyclosporine—ABCB1—cerebellum—malignant glioma	0.000274	0.00112	CbGeAlD
Cyclosporine—ABCB1—brain—malignant glioma	0.000223	0.000909	CbGeAlD
Cyclosporine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.75e-05	4.3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD80—malignant glioma	1.75e-05	4.3e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.75e-05	4.3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—APC—malignant glioma	1.75e-05	4.3e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—malignant glioma	1.75e-05	4.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SPHK1—malignant glioma	1.74e-05	4.27e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NCOR1—malignant glioma	1.74e-05	4.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.73e-05	4.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGF—malignant glioma	1.73e-05	4.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NCOR1—malignant glioma	1.72e-05	4.23e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTPN11—malignant glioma	1.72e-05	4.22e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.72e-05	4.22e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CD—malignant glioma	1.71e-05	4.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCAN—malignant glioma	1.71e-05	4.19e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—malignant glioma	1.71e-05	4.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.71e-05	4.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.7e-05	4.18e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—BCHE—malignant glioma	1.7e-05	4.18e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CASP3—malignant glioma	1.7e-05	4.17e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—malignant glioma	1.69e-05	4.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.69e-05	4.16e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—malignant glioma	1.69e-05	4.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTT1—malignant glioma	1.69e-05	4.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.68e-05	4.13e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—malignant glioma	1.67e-05	4.1e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—BRAF—malignant glioma	1.64e-05	4.04e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CD—malignant glioma	1.64e-05	4.04e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.63e-05	4e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CAV1—malignant glioma	1.61e-05	3.95e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—malignant glioma	1.61e-05	3.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.61e-05	3.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.6e-05	3.94e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—malignant glioma	1.6e-05	3.94e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT2—malignant glioma	1.6e-05	3.93e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—malignant glioma	1.59e-05	3.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS1—malignant glioma	1.59e-05	3.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.58e-05	3.88e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—malignant glioma	1.58e-05	3.88e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PPARG—malignant glioma	1.57e-05	3.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.55e-05	3.8e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—malignant glioma	1.55e-05	3.79e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CD—malignant glioma	1.54e-05	3.78e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.54e-05	3.77e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CAV1—malignant glioma	1.53e-05	3.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTT1—malignant glioma	1.51e-05	3.71e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CB—malignant glioma	1.49e-05	3.67e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—malignant glioma	1.48e-05	3.64e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTT1—malignant glioma	1.47e-05	3.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—BCHE—malignant glioma	1.47e-05	3.62e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGF2—malignant glioma	1.47e-05	3.62e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CG—malignant glioma	1.47e-05	3.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.46e-05	3.59e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.46e-05	3.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.46e-05	3.57e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—malignant glioma	1.45e-05	3.56e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—malignant glioma	1.44e-05	3.53e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CB—malignant glioma	1.43e-05	3.52e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CD—malignant glioma	1.43e-05	3.51e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.43e-05	3.51e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—malignant glioma	1.43e-05	3.5e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—malignant glioma	1.42e-05	3.49e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CAV1—malignant glioma	1.42e-05	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.41e-05	3.47e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—malignant glioma	1.41e-05	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.41e-05	3.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.41e-05	3.46e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CAV1—malignant glioma	1.4e-05	3.44e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—malignant glioma	1.4e-05	3.44e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CG—malignant glioma	1.39e-05	3.42e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.39e-05	3.41e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS1—malignant glioma	1.38e-05	3.39e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MDM2—malignant glioma	1.38e-05	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—IDH2—malignant glioma	1.38e-05	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTT1—malignant glioma	1.38e-05	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.38e-05	3.38e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—RAF1—malignant glioma	1.37e-05	3.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.36e-05	3.35e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—malignant glioma	1.36e-05	3.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—malignant glioma	1.35e-05	3.32e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—malignant glioma	1.34e-05	3.3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—malignant glioma	1.34e-05	3.29e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—malignant glioma	1.33e-05	3.26e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—malignant glioma	1.32e-05	3.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CAT—malignant glioma	1.32e-05	3.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—BCHE—malignant glioma	1.32e-05	3.23e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—malignant glioma	1.31e-05	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.3e-05	3.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.3e-05	3.19e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—malignant glioma	1.3e-05	3.18e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.29e-05	3.18e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—malignant glioma	1.29e-05	3.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS1—malignant glioma	1.29e-05	3.17e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—malignant glioma	1.29e-05	3.17e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—malignant glioma	1.29e-05	3.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.29e-05	3.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—BCHE—malignant glioma	1.28e-05	3.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.28e-05	3.14e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC5A5—malignant glioma	1.27e-05	3.11e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—malignant glioma	1.26e-05	3.1e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—malignant glioma	1.25e-05	3.06e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—malignant glioma	1.24e-05	3.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NCOR1—malignant glioma	1.24e-05	3.05e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—malignant glioma	1.24e-05	3.04e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—malignant glioma	1.24e-05	3.03e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—malignant glioma	1.23e-05	3.03e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.23e-05	3.02e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—malignant glioma	1.22e-05	3.01e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—malignant glioma	1.22e-05	3e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.22e-05	2.99e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—BCHE—malignant glioma	1.21e-05	2.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—BCHE—malignant glioma	1.2e-05	2.94e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.2e-05	2.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.19e-05	2.92e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.18e-05	2.91e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—malignant glioma	1.18e-05	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—IDH1—malignant glioma	1.18e-05	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—malignant glioma	1.17e-05	2.88e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.17e-05	2.87e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—malignant glioma	1.16e-05	2.84e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SPHK1—malignant glioma	1.15e-05	2.81e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CAT—malignant glioma	1.14e-05	2.8e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—malignant glioma	1.13e-05	2.78e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—malignant glioma	1.12e-05	2.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.12e-05	2.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.12e-05	2.76e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—malignant glioma	1.12e-05	2.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.12e-05	2.75e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—malignant glioma	1.11e-05	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.11e-05	2.73e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—malignant glioma	1.09e-05	2.67e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—malignant glioma	1.08e-05	2.65e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NCOR1—malignant glioma	1.08e-05	2.65e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—malignant glioma	1.07e-05	2.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	2.61e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—malignant glioma	1.06e-05	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—malignant glioma	1.05e-05	2.57e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—malignant glioma	1.04e-05	2.54e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—malignant glioma	1.02e-05	2.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CAT—malignant glioma	1.02e-05	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CAV1—malignant glioma	1.01e-05	2.49e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CAT—malignant glioma	9.94e-06	2.44e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—malignant glioma	9.88e-06	2.43e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—malignant glioma	9.79e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—malignant glioma	9.79e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—malignant glioma	9.7e-06	2.38e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—malignant glioma	9.7e-06	2.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.68e-06	2.38e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—malignant glioma	9.63e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—malignant glioma	9.63e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NCOR1—malignant glioma	9.62e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—malignant glioma	9.54e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—malignant glioma	9.42e-06	2.31e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NCOR1—malignant glioma	9.39e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CAT—malignant glioma	9.37e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CAT—malignant glioma	9.29e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—malignant glioma	9.24e-06	2.27e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—malignant glioma	9.22e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—malignant glioma	9.19e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—malignant glioma	9.11e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—malignant glioma	9.08e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—malignant glioma	8.92e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—malignant glioma	8.9e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NCOR1—malignant glioma	8.85e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CAV1—malignant glioma	8.78e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NCOR1—malignant glioma	8.77e-06	2.15e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—malignant glioma	8.73e-06	2.14e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—malignant glioma	8.54e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS1—malignant glioma	8.51e-06	2.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—malignant glioma	8.46e-06	2.08e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.39e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—malignant glioma	8.17e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—malignant glioma	8.12e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—malignant glioma	8e-06	1.96e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCHE—malignant glioma	7.91e-06	1.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CAV1—malignant glioma	7.84e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.81e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—malignant glioma	7.72e-06	1.9e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CAV1—malignant glioma	7.65e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—malignant glioma	7.61e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.49e-06	1.84e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—malignant glioma	7.44e-06	1.83e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CAV1—malignant glioma	7.21e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CAV1—malignant glioma	7.15e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.14e-06	1.75e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—malignant glioma	7.14e-06	1.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—malignant glioma	7.08e-06	1.74e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.03e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—malignant glioma	7.01e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—malignant glioma	6.97e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—malignant glioma	6.89e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—malignant glioma	6.84e-06	1.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.83e-06	1.68e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—malignant glioma	6.73e-06	1.65e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—malignant glioma	6.68e-06	1.64e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.57e-06	1.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.51e-06	1.6e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—malignant glioma	6.5e-06	1.6e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—malignant glioma	6.34e-06	1.56e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—malignant glioma	6.29e-06	1.55e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—malignant glioma	6.28e-06	1.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—malignant glioma	6.28e-06	1.54e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—malignant glioma	6.21e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.13e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—malignant glioma	6.13e-06	1.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CAT—malignant glioma	6.12e-06	1.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—malignant glioma	6.12e-06	1.5e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—malignant glioma	6.07e-06	1.49e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—malignant glioma	6.02e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.97e-06	1.47e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOR1—malignant glioma	5.78e-06	1.42e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.77e-06	1.42e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.72e-06	1.41e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—malignant glioma	5.59e-06	1.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.47e-06	1.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—malignant glioma	5.42e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—malignant glioma	5.34e-06	1.31e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—malignant glioma	5.31e-06	1.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—malignant glioma	5.3e-06	1.3e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—malignant glioma	5.29e-06	1.3e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.03e-06	1.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.99e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.99e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.94e-06	1.21e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—malignant glioma	4.92e-06	1.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—malignant glioma	4.88e-06	1.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—malignant glioma	4.73e-06	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CAV1—malignant glioma	4.71e-06	1.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—malignant glioma	4.62e-06	1.13e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—malignant glioma	4.35e-06	1.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—malignant glioma	4.32e-06	1.06e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—malignant glioma	4.31e-06	1.06e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.29e-06	1.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—malignant glioma	4.14e-06	1.02e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.78e-06	9.27e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.74e-06	9.18e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—malignant glioma	3.53e-06	8.65e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.34e-06	8.19e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.29e-06	8.08e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—malignant glioma	3.26e-06	8e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—malignant glioma	3.26e-06	7.99e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.07e-06	7.53e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—malignant glioma	3.05e-06	7.5e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.04e-06	7.47e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—malignant glioma	2.84e-06	6.98e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—malignant glioma	2.73e-06	6.69e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—malignant glioma	2.66e-06	6.53e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—malignant glioma	2.51e-06	6.15e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—malignant glioma	2.48e-06	6.1e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.01e-06	4.92e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—malignant glioma	1.64e-06	4.02e-06	CbGpPWpGaD
